Daniel Grau, Avilar Therapeutics CEO

Ex­clu­sive: Sanofi, Astel­las ven­ture arms add cash to Avi­lar's 'AT­AC' mis­sion

The ven­ture arms of Sanofi and Astel­las have grown their in­vest­ment in Avi­lar Ther­a­peu­tics to help steer the biotech through a niche of the grow­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.